PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 22766315-3 2012 Aims of our study were to investigate if real life COPD treatment affects peripheral blood NK cells total count and their receptors expression and to assess if different doses of formoterol and budesonide, administered alone or in combination, are able to modulate the surface expression of activating (NKp30, NKp44, NKp46 and NKG2D) and inhibitory (KIR2DL2/L3, KIR3DL1 and NKG2A) receptors on peripheral blood NK cells of COPD patients. Budesonide 194-204 killer cell lectin like receptor K1 Homo sapiens 327-332 22766315-13 2012 Even if in vitro experiments with budesonide, alone or in combination with formoterol, showed a modulation of NKG2D receptor expression and IFN-gamma production, our ex vivo results show that real life LABA and ICS treatment does not influence peripheral NK cells count and their receptors phenotype. Budesonide 34-44 killer cell lectin like receptor K1 Homo sapiens 110-124